Saraswat AL - Search Results

1

Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs).

Saraswat AL, Vartak R, Hegazy R, Patel A, Patel K. Saraswat AL, et al. Drug Discov Today. 2023 Jan;28(1):103387. doi: 10.1016/j.drudis.2022.103387. Epub 2022 Sep 29. Drug Discov Today. 2023. PMID: 36184017 Review.

2

Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer.

Saraswat A, Patki M, Fu Y, Barot S, Dukhande VV, Patel K. Saraswat A, et al. Nanomedicine (Lond). 2020 Aug;15(18):1761-1777. doi: 10.2217/nnm-2020-0156. Epub 2020 Jul 23. Nanomedicine (Lond). 2020. PMID: 32698663

3

A novel gene therapy for neurodegenerative Lafora disease via EPM2A-loaded DLinDMA lipoplexes.

Vemana HP, Saraswat A, Bhutkar S, Patel K, Dukhande VV. Vemana HP, et al. Nanomedicine (Lond). 2021 Jun;16(13):1081-1095. doi: 10.2217/nnm-2020-0477. Epub 2021 May 7. Nanomedicine (Lond). 2021. PMID: 33960213 Free PMC article.

4

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro.

Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK, Patel K. Vartak R, et al. Nanomedicine (Lond). 2021 Jun;16(14):1187-1202. doi: 10.2217/nnm-2020-0475. Epub 2021 May 13. Nanomedicine (Lond). 2021. PMID: 33982600 Free PMC article.

5

In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells.

Patki M, Saraswat A, Bhutkar S, Dukhande V, Patel K. Patki M, et al. Exp Cell Res. 2021 Aug 15;405(2):112660. doi: 10.1016/j.yexcr.2021.112660. Epub 2021 May 25. Exp Cell Res. 2021. PMID: 34048785

6

Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma.

Fu Y, Saraswat A, Wei Z, Agrawal MY, Dukhande VV, Reznik SE, Patel K. Fu Y, et al. Pharmaceutics. 2021 Jul 1;13(7):1005. doi: 10.3390/pharmaceutics13071005. Pharmaceutics. 2021. PMID: 34371697 Free PMC article.

7

Stromal disruption facilitating invasion of a 'nano-arsenal' into the solid tumor.

Fu Y, Saraswat AL, Monpara J, Patel K. Fu Y, et al. Among authors: saraswat al. Drug Discov Today. 2022 Apr;27(4):1132-1141. doi: 10.1016/j.drudis.2021.11.015. Epub 2021 Nov 22. Drug Discov Today. 2022. PMID: 34823002 Review.

8

Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir.

Saraswat A, Vartak R, Patki M, Patel K. Saraswat A, et al. Cannabis Cannabinoid Res. 2023 Dec;8(6):1008-1018. doi: 10.1089/can.2021.0109. Epub 2021 Dec 16. Cannabis Cannabinoid Res. 2023. PMID: 34918945

9

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy.

Saraswat A, Vemana HP, Dukhande VV, Patel K. Saraswat A, et al. Heliyon. 2022 Jan 3;8(1):e08702. doi: 10.1016/j.heliyon.2021.e08702. eCollection 2022 Jan. Heliyon. 2022. PMID: 35036599 Free PMC article.

10

Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.

Vartak R, Saraswat A, Yang Y, Chen ZS, Patel K. Vartak R, et al. Pharm Res. 2022 Nov;39(11):2745-2759. doi: 10.1007/s11095-022-03184-3. Epub 2022 Feb 10. Pharm Res. 2022. PMID: 35146591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters